Noha Nafee

Noha Nafee

Auto-generated profile, based on publicly available information

Noha Nafee

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
NNNoha Nafee
Noha Nafee
AHAyman Husari
Ayman Husari
CMChristine K. Maurer
Christine K. Maurer
CLCenbin Lu
Cenbin Lu
CRChiara de Rossi
Chiara de Rossi
Marc SchneiderMarc Schneider
Marc Schneider

1 September 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NNNoha Nafee
Noha Nafee
AYAlaa Youssef
Alaa Youssef
HEHanan M. El-Gowelli
Hanan M. El-Gowelli
HAHeba Asem
Heba Asem
SKSherif Kandil
Sherif Kandil

1 July 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HAHeba Abd El Azim
Heba Abd El Azim
NNNoha Nafee
Noha Nafee
ARAlyaa Ramadan
Alyaa Ramadan
NKNawal Khalafallah
Nawal Khalafallah

1 August 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MZMariam Zewail
Mariam Zewail
NNNoha Nafee
Noha Nafee
MHMaged W. Helmy
Maged W. Helmy
NBNabila Boraie
Nabila Boraie

1 January 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SMShaimaa Makled
Shaimaa Makled
NNNoha Nafee
Noha Nafee
NBNabila Boraie
Nabila Boraie

26 October 2017 in Journal of Drug Targeting
Verified
Journal Article
Closed access
NNNoha Nafee
Noha Nafee
MZMariam Zewail
Mariam Zewail
NBNabila Boraie
Nabila Boraie
Alendronate (ALN) is a BCS III bone resorption inhibitor, with very poor oral bioavailability. Our approach is to develop a minimally invasive thermogelling system for prolonged local delivery of ALN. For this, different chitosan-based thermogels were developed and characterised in terms of gelation time, injectability, pH, viscosity and thermoreversibility. Chitosan/β-glycerophosphate (CS/βGP) hydrogel pursued temperature-dependent, thermoreversible gelation behaviour and was thus selected for drug loading. Increasing ALN concentration resulted in hydrogels with lower porosity and higher density. FTIR and DSC proved interaction between ALN, CS with βGP. CS/βGP hydrogel ensured controlled ALN release over 45-65 days depending on initial ALN loading. Freeze drying improved the shelf-life stability with minor impact on thermogelling character. In vivo injection of plain and ALN-loaded hydrogel in rats rapidly gelled 15 min post-injection. Based on histological examination, ALN-loaded thermogel showed less inflammatory response, faster proliferation and maturation of granulation tissue relative to plain thermogel. Hydrogels excised 21-days post-injection proved the biocompatibility and biodegradability of the system. The presented chitosan-based thermogel has significant positive attributes for site-specific, time-controlled, intra-articular delivery of ALN.